πŸ‡ΊπŸ‡Έ FDA
Patent

US 8556882

Inducible interleukin-12

granted A61KA61K38/00A61P

Quick answer

US patent 8556882 (Inducible interleukin-12) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P35/00